Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

We just began a large new study on
Autism, ADHD, Anxiety & Depression in 12-17 year-olds.
Read more and learn how you can help!

TitlePsychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
Publication TypeJournal Article
Year of Publication2014
AuthorsTang, SX, Yi, JJ, Calkins, ME, Whinna, DA, Kohler, CG, Souders, MC, McDonald-McGinn, DM, Zackai, EH, Emanuel, BS, Gur, RC, Gur, RE
JournalPsychol Med
Date Published2014 Apr
KeywordsAdolescent, Adult, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Child, DiGeorge Syndrome, Female, Humans, Male, Mental Health Services, Middle Aged, Mood Disorders, Prevalence, Psychotic Disorders, Young Adult

BACKGROUND: Chromosome 22q11.2 deletion syndrome (22q11DS) is a common genetic disorder with high rates of psychosis and other psychopathologies, but few studies discuss treatment. Our aim was to characterize the prevalence and treatment of major psychiatric illnesses in a well-characterized sample of individuals with 22q11DS.METHOD: This was a cross-sectional study of 112 individuals aged 8 to 45 years with a confirmed diagnosis of 22q11DS. Each participant was administered a modified Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) and the Structured Interview for Prodromal Syndromes (SIPS). Phenotypes assessed were threshold and subthreshold psychosis, depression, mania, generalized and separation anxiety, obsessions/compulsions, inattention/hyperactivity and substance use. Histories of mental health care and current psychotropic treatment were obtained.RESULTS: Psychopathology was common, with 79% of individuals meeting diagnostic criteria for a disorder at the time of assessment. Diagnoses of psychosis were made in 11% of cases, attenuated positive symptom syndrome (APS) in 21%, and 47% experienced significant subthreshold symptoms. Peak occurrence of psychosis risk was during adolescence (62% of those aged 12-17 years). Criteria for a mood disorder were met by 14%, for anxiety disorder 34% and for attention deficit hyperactivity disorder (ADHD) 31%. Mental health care had been received by 63% of individuals in their lifetime, but only 40% continued therapy and 39% used psychotropics. Antipsychotics were used by 42% of participants with psychosis and none of the participants with APS. Half of those at risk for psychosis were receiving no mental health care.CONCLUSIONS: Psychopathology is common in 22q11DS but is not adequately treated or clinically followed. Particular attention should be paid to subthreshold psychotic symptoms, especially in adolescents.

Alternate JournalPsychol Med
PubMed ID24016317
PubMed Central IDPMC4461220
Grant ListU01 MH087626 / MH / NIMH NIH HHS / United States
K08 MH079364 / MH / NIMH NIH HHS / United States
MH087626 / MH / NIMH NIH HHS / United States
K08 MH 079364 / MH / NIMH NIH HHS / United States
MH087636 / MH / NIMH NIH HHS / United States
U01 MH087636 / MH / NIMH NIH HHS / United States
Leave a Comment